Juvelook (PDLLA): What It Is, What the Studies Show and Its Approval Status

In short
- Juvelook is PDLLA particles with hyaluronic acid. The studies found had 20 to 40 participants and short follow-up. [1][2][5]
- A randomized trial against PLLA on the nasolabial fold found similar improvement, but the maker paid for it. [2]
- PDLLA lumps do not dissolve with hyaluronidase, and no official document opened confirms US FDA or Thai FDA status, so check it yourself. [3][7][8]
What is Juvelook and what is it made of?
Juvelook is an injectable made by the Korean company VAIM, containing PDLLA particles mixed with hyaluronic acid. [1][4] PDLLA stands for poly-D,L-lactic acid, a polymer the body can break down and tolerate. [1] A maker image in a review shows round, porous particles 30 to 70 micrometres across, small enough to pass through a needle. [1]
The authors of a maker-funded study explain that PDLLA stimulates collagen production in a way similar to PLLA, while non-cross-linked hyaluronic acid makes the skin look hydrated right away. [2] This is the authors' description of the mechanism, not a confirmed result for every user.
PDLLA and PLLA trigger a mild inflammatory tissue response that raises type I collagen at the injection site. [3] That is why this group is called collagen stimulators. For the whole group, see [[collagen-stimulator-types-explained]].
What does Juvelook do, and what did the studies measure?
| Study | Participants | What was measured and reported | Limits |
|---|---|---|---|
| Facial skin study covered in the 2024 review | 20 people | Elasticity, firmness and hydration; the authors reported improvement. [1] | The review rated the evidence level 4 of 5 (1 is highest). [1] |
| Stretch-mark study on the abdomen covered in the 2024 review, used together with a laser | 20 people | Skin texture, elasticity and the look of the stretch marks improved. [1] | Used with a laser, so the result is not from Juvelook alone. [1] |
| Park et al. 2026: nasolabial fold against PLLA, randomized split-face | 33 people | Wrinkle Severity Rating Scale on photographs improved from baseline on both sides and was similar. [2] | The maker funded it; short follow-up; scores depend on the assessor's opinion. [2] |
| Ajou University trial record: sun-damaged skin against saline, randomized split-face | 40 people | Skin lightness measured with a colour meter. [5] | The record shows no results, and its last recorded status is unknown (last verified June 2023). [5] |
Scroll the table →
The studies measured skin elasticity, hydration and the severity of the nasolabial fold, but they had 20 to 40 participants and short follow-up, so long-term results are unknown. [1][2][5] The table below lists the studies that could be opened, with the limits of each.
Park and colleagues (2026) compared a PDLLA product with PLLA on the nasolabial fold, one on each side of the face, in 33 participants. The authors concluded that both sides improved significantly from baseline and about equally, so they called the PDLLA product non-inferior to PLLA. [2] The authors name their own limits: short follow-up and rating tools based on an assessor's opinion. [2]
No standard figure for how long the effect lasts was found in the studies opened. Park's study assessed up to week 24 from the start of injections. [2] A result measured on photographs or with an instrument does not mean every user sees the same thing.
The studies opened compared only with PLLA or saline, not with other skin boosters. [2][5] So they cannot say which product suits which skin. For a way to choose, read [[skin-booster-which-for-which-skin]].
How is PDLLA different from PLLA?
PDLLA and PLLA are both polylactic acid polymers, but the particles differ in shape: PDLLA is round and porous, while PLLA is irregular and dense. [2] The authors of Park's study, which a PDLLA maker funded, explain that PDLLA is amorphous, so it breaks down fairly quickly and from the core outward. [2]
That is the authors' explanation. It is not proof that PDLLA is safer or better than PLLA in real use. The one head-to-head study opened found similar results on the nasolabial fold. [2]
The US FDA lists PLLA among the materials it describes for dermal fillers and says its effects become more apparent over several weeks. [7] For PLLA in detail, read [[sculptra-plla-explained]].
What are the cautions with Juvelook? Lumps and blood vessel risk
The main cautions are lumps under the skin that hyaluronidase does not dissolve and that are hard to treat, plus a rare but serious risk if product enters a blood vessel by accident. [3][4][6] A 2024 review lists the complications of PDLLA as granulomas (firm, red lumps from the body's reaction), non-inflammatory lumps from uneven spread of the product, and movement of the product. [1]
A 2025 guideline on managing these lumps explains that they usually appear within several months of injection, from product that piles up or spreads unevenly. Unlike lumps from hyaluronic acid fillers, which hyaluronidase can dissolve, PDLLA lumps do not respond to simple enzyme treatment and respond poorly to steroids. [3] Park's study gives the usual timing for polylactic acid products as about 1 to 2 months for lumps and much later, about 6 to 24 months, for granulomas. [2]
Treating a lump has several levels, from non-invasive methods up to surgery if it does not go away. [3] That is a doctor's job; do not try to treat it yourself from internet advice.
A rare but serious risk of any dermal filler is accidental injection into a blood vessel. The US FDA says this can cause tissue death, vision problems including blindness, or stroke. [6] This is information for dermal fillers in general, not only Juvelook.
A team led by a doctor from Ramathibodi Hospital injected Juvelook into the ear artery of 112 rabbits. At one injected volume blood flow was briefly blocked and returned on its own within 5 minutes, and no skin death was seen. [4] The first author is a medical advisor to VAIM. [4] Animal results do not confirm safety in people.
The usual effects after a dermal filler, per the FDA, are bruising, redness, swelling, pain and itching. [6] If you have severe pain, skin colour change, an open sore or a change in vision, contact the doctor who injected you at once.
Is Juvelook approved? The status that can be checked
In the official documents that could be opened, there is no evidence that Juvelook is approved by the US FDA or registered with the Thai FDA, so ask for the registration number and check it yourself. [5][7][8] The information in this section was checked on 12 October 2026.
United States: the FDA page on dermal fillers describes four materials: hyaluronic acid, calcium hydroxylapatite, PLLA and PMMA. PDLLA is not among them. [7] That page says it was last updated in 2020 and tells readers to search the FDA approval database, so recheck the current database. [7]
Europe: the Ajou University trial record says Juvelook received CE approval in Europe in 2020. [5] That statement comes from the researcher, not from a regulator's document.
South Korea and Thailand: no official document from the Korean regulator (MFDS) or the Thai FDA that confirms Juvelook's status could be opened, so this article does not say whether it is approved. In its warning about exosomes the Thai FDA advised the public to check the product registration number and the advertising permit number, and to call hotline 1556 for side effects. [8] If a clinic says Juvelook has passed the Thai FDA, ask to see the registration number and check it with the Thai FDA yourself.
What should you ask the doctor about Juvelook before deciding?
Ask about the exact product, its registration number, the doctor's experience, and the plan if a lump or other problem appears; injections must be done by a licensed doctor. [6] The US FDA advises choosing a licensed provider trained in dermal fillers and never injecting dermal fillers yourself. [6]
The list below is a starting point. The right answers depend on your skin, your health history and the product the clinic actually uses.
- Which exact product is used? Ask to see the box, the label and the registration number. [8]
- How has the doctor managed lumps under the skin after PDLLA products, and does the clinic book follow-up visits? [3]
- Do your allergies, raised scars or earlier filler treatment matter, since these studies excluded people with such features? [2]
- Which symptoms mean you should call the clinic at once, such as severe pain, skin colour change, an open sore or a change in vision? [6]
- How is the result measured, and when does the clinic assess it?
FAQ
What is Juvelook?
Juvelook is an injectable made by the Korean company VAIM from PDLLA particles with hyaluronic acid, designed by the maker to stimulate collagen and add hydration. [1][2]
What does Juvelook do?
The studies opened measured elasticity, hydration and wrinkles at the nasolabial fold, with 20 to 40 participants and short follow-up, so long-term results cannot be concluded. [1][2][5]
What is the difference between PDLLA and PLLA?
PDLLA particles are round and porous, while PLLA particles are irregular and dense. [2] A head-to-head study on the nasolabial fold found similar results, but a PDLLA maker paid for it. [2]
Can Juvelook cause lumps, and how are they treated?
Lumps under the skin are a reported complication of PDLLA. [1] They usually appear within several months, do not dissolve with hyaluronidase, and need a doctor to choose the treatment. [3]
Is Juvelook approved by the Thai FDA or the US FDA?
No official document that confirms its Thai FDA status could be opened. PDLLA is not in the dermal filler materials listed on the US FDA page, last updated in 2020. [7] Ask for the registration number and check it with the Thai FDA. [8]
How long does Juvelook last?
No standard figure was found in the studies opened. The study against PLLA assessed up to week 24 from the start of injections, and its authors say the follow-up is too short to judge long-term complications. [2]
This information is general knowledge and does not replace a doctor's advice. Every procedure should be done by a licensed doctor.
References
- Lee KWA, Chan LKW, Lee AWK, Lee CH, Wong STH, Yi KH. Poly-d,l-lactic Acid (PDLLA) Application in Dermatology: A Literature Review. Polymers (Basel). 2024;16(18):2583. https://pmc.ncbi.nlm.nih.gov/articles/PMC11434839/ (DOI 10.3390/polym16182583)Back to text
- Park JY, Im DJ, Jeon HD, Kim HJ, Rhee DY, Goo BL, Han KH, Chang Z, Kim HS. A Split Face Study Comparing the Effect of a PDLLA Based Product and PLLA on the Nasolabial Fold (NLF). Skin Research and Technology. 2026;32(1):e70324. Funded by Vaim Co., Ltd. https://pmc.ncbi.nlm.nih.gov/articles/PMC12802405/ (DOI 10.1111/srt.70324)Back to text
- Magacho-Vieira FN, Ducati EPJ. Clinical Management of Poly-D,L-Lactic Acid Nodules: A Guideline With Diagnostic and Treatment Flowchart. Journal of Cosmetic Dermatology. 2025;24(4):e70158. https://pmc.ncbi.nlm.nih.gov/articles/PMC11956123/ (DOI 10.1111/jocd.70158)Back to text
- Vachiramon V, Boonyarattanasoonthorn T, Rattanapinyopituk K, Duangbupha J, Limprasutr V, Kijtawornrat A, Wan J. Investigation of Vascular Behaviour and Tissue Response Following Intra-Arterial Injection of Poly D,L-Lactic Acid with Hyaluronic Acid Hybrid Biostimulators (Juvelook and Juvelook Volume) in a Rabbit Ear Model. Journal of Functional Biomaterials. 2026;17(9):447. Rabbit study; the first author is a medical advisor to VAIM. https://pmc.ncbi.nlm.nih.gov/articles/PMC13608762/ (DOI 10.3390/jfb17090447)Back to text
- Ajou University School of Medicine (sponsor-investigator Jin Cheol Kim). A Prospective, Split-face, Randomized Study of the Poly-D, L Lactic Acid (PDLLA) for Photoaged Skin. ClinicalTrials.gov NCT05913102; record last verified June 2023, status unknown, no results posted. https://clinicaltrials.gov/study/NCT05913102Back to text
- US Food and Drug Administration. Dermal Fillers (Soft Tissue Fillers). FDA. Content current as of 07/06/2023 (US date format); accessed 2026-10-12. https://www.fda.gov/medical-devices/aesthetic-cosmetic-devices/dermal-fillers-soft-tissue-fillersBack to text
- US Food and Drug Administration. FDA-Approved Dermal Fillers. FDA. Content current as of 11/09/2020 (US date format); accessed 2026-10-12. https://www.fda.gov/medical-devices/aesthetic-cosmetic-devices/fda-approved-dermal-fillersBack to text
- ผู้จัดการออนไลน์. อย.เตือนเทคโนโลยี Exosome ฉีดหน้า ยังไม่ได้ขึ้นทะเบียน อย่าหลงเชื่อทำ. 14 กรกฎาคม 2566 (คำแนะนำของ อย. เรื่องตรวจเลขทะเบียน เลขอนุญาตโฆษณา และสายด่วน 1556). https://mgronline.com/qol/detail/9660000063880Back to text
Skin Booster Results and Aftercare: How Long Until You See Results, and What to Avoid After Injection
Exosome Facial and Exosome Skincare: What They Are, What the Studies Show and Approval Status
Meso Fat vs Masseter Botox: How to Slim the Face
Fat Dissolving Injections for Belly and Arms: The Facts
Collagen Stimulators Explained: PLLA, PDLLA, PN, Profhilo and Exosomes Compared
What Are Fat Dissolving Injections (Meso Fat)? A Guide
Double Chin Injections: Kybella vs Meso-Fat Blends